[{"address1": "3980 Premier Drive", "address2": "Suite 310", "city": "High Point", "state": "NC", "zip": "27265", "country": "United States", "phone": "336 841 0300", "fax": "336 841 0310", "website": "https://vtvtherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. The company was incorporated in 2015 and is headquartered in High Point, North Carolina.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul J. Sekhri M.Sc.", "age": 67, "title": "CEO, President & Chairman of the Board", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 914826, "exercisedValue": 0, "unexercisedValue": 44577}, {"maxAge": 1, "name": "Dr. Michael Steven Tung M.B.A., M.D.", "age": 51, "title": "Executive VP & CFO", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Barry K. Brown", "age": 64, "title": "Chief Accounting Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 311977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carmen  Valcarce Ph.D.", "title": "Chief Scientific Officer & Executive VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth M. Keiley", "age": 59, "title": "Executive VP & General Counsel", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard S. Nelson", "age": 55, "title": "Executive VP of Corporate Development & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 201081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas  Strack M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin  Lafontaine", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 37.25, "open": 37.83, "dayLow": 35.59, "dayHigh": 39.7114, "regularMarketPreviousClose": 37.25, "regularMarketOpen": 37.83, "regularMarketDayLow": 35.59, "regularMarketDayHigh": 39.7114, "payoutRatio": 0.0, "beta": 0.481, "forwardPE": -8.011254, "volume": 17726, "regularMarketVolume": 17726, "averageVolume": 14261, "averageVolume10days": 30300, "averageDailyVolume10Day": 30300, "bid": 31.38, "ask": 26.3, "bidSize": 1, "askSize": 1, "marketCap": 140154064, "fiftyTwoWeekLow": 13.46, "fiftyTwoWeekHigh": 44.0, "allTimeHigh": 560.0, "allTimeLow": 7.38, "priceToSalesTrailing12Months": 8244.356, "fiftyDayAverage": 33.0762, "twoHundredDayAverage": 22.148846, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 343479584, "profitMargins": 0.0, "floatShares": 2902505, "sharesOutstanding": 3938018, "sharesShort": 27101, "sharesShortPriorMonth": 19140, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0069, "heldPercentInsiders": 0.23603001, "heldPercentInstitutions": 0.29157, "shortRatio": 2.15, "shortPercentOfFloat": 0.0111, "impliedSharesOutstanding": 3938018, "bookValue": 5.685, "priceToBook": 6.2603345, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -23470000, "trailingEps": -3.3, "forwardEps": -4.4425, "lastSplitFactor": "1:40", "lastSplitDate": 1700524800, "enterpriseToRevenue": 20204.682, "enterpriseToEbitda": -11.534, "52WeekChange": 1.5485141, "SandP52WeekChange": 0.14725316, "quoteType": "EQUITY", "currentPrice": 35.59, "targetHighPrice": 67.0, "targetLowPrice": 35.0, "targetMeanPrice": 47.25, "targetMedianPrice": 43.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 98504000, "totalCashPerShare": 7.938, "ebitda": -29779000, "totalDebt": 360000, "quickRatio": 9.692, "currentRatio": 9.786, "totalRevenue": 17000, "debtToEquity": 0.51, "revenuePerShare": 0.001, "returnOnAssets": -0.26125, "returnOnEquity": -0.64165, "grossProfits": -16170000, "freeCashflow": -11116500, "operatingCashflow": -20829000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -1753.8236, "financialCurrency": "USD", "symbol": "VTVT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1438263000000, "postMarketChangePercent": -2.5086377, "postMarketPrice": 35.59, "postMarketChange": -0.9157982, "regularMarketChange": -1.6599998, "regularMarketDayRange": "35.59 - 39.7114", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 14261, "fiftyTwoWeekLowChange": 22.130001, "fiftyTwoWeekLowChangePercent": 1.6441308, "fiftyTwoWeekRange": "13.46 - 44.0", "fiftyTwoWeekHighChange": -8.41, "fiftyTwoWeekHighChangePercent": -0.19113636, "fiftyTwoWeekChangePercent": 154.85141, "marketState": "CLOSED", "shortName": "vTv Therapeutics Inc.", "longName": "vTv Therapeutics Inc.", "earningsTimestampStart": 1755201600, "earningsTimestampEnd": 1755201600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.3, "epsForward": -4.4425, "epsCurrentYear": -4.295, "priceEpsCurrentYear": -8.28638, "fiftyDayAverageChange": 2.5138016, "fiftyDayAverageChangePercent": 0.07600032, "twoHundredDayAverageChange": 13.4411545, "twoHundredDayAverageChangePercent": 0.60685575, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1768597804, "regularMarketTime": 1768597200, "exchange": "NCM", "messageBoardId": "finmb_304063261", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.4563756, "regularMarketPrice": 35.59, "displayName": "vTv Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]